|
Cabazitaxel Clinical Trials
7 actively recruiting trials across 6 locations
Also known as: JEVTANA®, Jevtana, RPR-116258A, RPR116258A, TXD258, Taxoid XRP6258, XRP-6258, XRP6258
Other1 trial
Birmingham, Alabama1 trial
Tucson, Arizona1 trial
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Banner University Medical Center - Tucson
Phase 2
Fayetteville, Arkansas1 trial
Duarte, California1 trial
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
City of Hope National Medical Center
Phase 3
La Jolla, California1 trial
Sarasota, Florida1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.